Screener
Ionis Pharmaceuticals IONS Ionis Operations — Net Income Loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Drug discovery | 29,120 | 30,255 | 57,677 | 57,244 |
| Drug development | 103,958 | 117,689 | 208,140 | 230,635 |
| Medical affairs | 11,318 | 7,826 | 21,307 | 13,468 |
| Manufacturing and development chemistry | 20,639 | 21,545 | 40,947 | 35,826 |
| R&D support | 26,974 | 20,607 | 49,405 | 41,159 |
| Selling, general and administrative | 130,075 | 81,081 | 262,012 | 148,061 |
| Other segment items (1) | 57,948 | 45,954 | 76,330 | 75,750 |
| Consolidated net income (loss) | $$(114,646) | $123,551 | $(207,174) | (23,387) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's ionis operations — net income loss?
- Ionis Pharmaceuticals (IONS) reported ionis operations — net income loss of -$114.65M in Q2 2026.
- How has Ionis Pharmaceuticals's ionis operations — net income loss changed year-over-year?
- Ionis Pharmaceuticals's ionis operations — net income loss decreased by 192.8% year-over-year, from $123.55M to -$114.65M.
- What is the long-term trend for Ionis Pharmaceuticals's ionis operations — net income loss?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — net income loss has grown at a 12.2% compound annual growth rate (CAGR), from -$269.72M to -$381.39M.
- What does ionis operations — net income loss mean?
- This is the bottom-line financial result for the segment, calculated as total revenue minus all operating expenses and other costs. It represents the segment's overall profitability or the extent of its investment-driven losses.
Ask your AI about Ionis Pharmaceuticals's ionis operations — net income loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude